ADMAADMA Biologics, Inc.
9.840USD-2.09%Mkt Cap: 2.20B $P/E: 13.863d ago
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internat…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.20B $
Enterprise Value43.93B $
Revenue (TTM)512.28M $
Gross Profit292.76M $
Net Income (TTM)146.93M $
Revenue/Share2.178 USD
Last Price9.840 USD
Fiscal Year EndDec 2025
MR QuarterMar 2021
Employees640
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)13.86
P/E (Forward)9.93
PEG—
EV/EBITDA195.96
EV/Revenue85.76
P/S4.27
P/B5.39
EPS (TTM)0.68
EPS (Forward)0.98
52W Range
7.21020% of range20.46
52W High20.46 USD
52W Low7.210 USD
Profitability
Gross Margin57.39%
Oper. Margin-123.39%
EBITDA Margin43.76%
Profit Margin28.80%
ROE30.78%
ROA23.54%
Growth
Revenue Growth15.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.40M $
CapEx (TTM)22.89M $
FCF Margin10.69%
FCF Yield2.48%
Net Debt41.75B $
Net Debt/EBITDA186.21
Balance Sheet
Debt/Equity0.17
Current Ratio6.97
Quick Ratio3.62
Book Value/Sh1.811 USD
Cash/Share249.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.00 USD
Upside (mean)+72.8%
Target Range12.00 USD – 21.00 USD
$12.00+72.8% to mean$21.00
# Analysts5
Ownership
Shares Out.223.98M
Float219.66M
Insiders1.97%
Institutions93.30%
Short Interest
Short Ratio8.5d
Short % Float12.06%
Short % Out.9.79%
Shares Short21.92M
Short (prev mo.)24.23M
Technical
SMA 508.916 (+10.4%)
SMA 20012.96 (-24.0%)
Beta0.77
S&P 52W Chg18.16%
Avg Vol (30d)2.54M
Avg Vol (10d)2.18M
Technical Indicators
RSI (14)59.5
MACD0.2878
MACD Signal0.2443
MACD Hist.+0.0435
BB Upper10.45 USD
BB Middle9.203 USD
BB Lower7.955 USD
BB Width27.12%
ATR (14)0.3927 USD
Vol Ratio (20d)0.58x